Catherine Uzan
Prof Catherine Uzan is an expert in Gynecology at Pitié-Salpêtrière Hospital (France). Catherine Uzan has authored 329 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 3 of them ongoing. SLR score: 995 (community average: 125). How the SLR is computed.
LeadR Profile
Gynecology
Subspecialties: Obstetrics - Oncology - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 329
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Beyond p53 status: the continued importance of histopathologic features for predicting lymph node metastasis in endometrial cancer. PMID 42435643 — confidence intervals, lymph nodes, genital neoplasms, female, neoplasms, multiple chronic conditions, neoplasm metastasis, genes, p53, odds ratio, lymph, endometrial neoplasms | Int J Gynecol Cancer | 2026 | 0 |
| De-escalating axillary surgery in early breast cancer: external validation of a retrospective cohort. PMID 42240899 — research design, breast neoplasms, neoplasms, drug therapy, chemotherapy, adjuvant, breast, therapeutics, chemotherapy | J Cancer Res Clin Oncol | 2026 | 0 |
| [How I Do … a robot-assisted laparoscopic polymyomectomie with temporary uterine artery occlusion?] PMID 41520883 — arteries, uterine artery | Gynecol Obstet Fertil Senol | 2026 | 0 |
| [(Even) less axillary surgery for breast cancer?]. PMID 41500427 — breast neoplasms, neoplasms, sentinel lymph node, breast | Gynecol Obstet Fertil Senol | 2026 | 0 |
| Comparison of Breast Reconstruction Strategies Using Exclusive Lipofilling or Prosthesis After Total Mastectomy for Breast Cancer: Satisfaction and Morbidity After More Than 2 Years. PMID 40916873 — mastectomy, breast neoplasms, mastectomy, simple, neoplasms, mammaplasty, breast, morbidity | Aesthet Surg J | 2025 | 1 |
Clinical Studies 10
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Risk reducing Strategies Including Fimbriectomy in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer NCT06726330 — sterilization, menopause, premature, surgical procedures, operative, genetic predisposition to disease, ovary, cardiovascular diseases, neoplasms, cognitive dysfunction, sterilization, tubal, germ-line mutation, osteoporosis, ovarian neoplasms, patient preference, prophylactic surgical procedures, menopause, tissues, genes, brca1, salpingo-oophorectomy, mutation, pelvic neoplasms, fallopian tubes, ovariectomy, carcinoma, women | N/A | Not yet recruiting | 2027 |
| PARa aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer NCT05581121 — radiotherapy, carcinoma, adenosquamous, lymph nodes, lymph node excision, uterine cervical neoplasms, brachytherapy, neoplasms, adenocarcinoma, laparoscopy, human papillomavirus 16, lymph, therapeutics, carcinoma | Phase 3 | Recruiting | 2023 |
| Breast Cancer Prevention and Screening Membership NCT05258539 — telephone, life style, breast neoplasms, risk assessment, neoplasms, risk management, breast, risk factors, women | N/A | Active not recruiting | 2022 |
LeadR Networks
Main global connection map